Loading clinical trials...

Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making | Clinical Trials | Clareo Health

WITHDRAWN

Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making

NCT02158754•CardioDx

View on ClinicalTrials.gov

Summary

Detailed Description

This retrospective study will investigate clinician behavior in diagnosing patients with possible obstructive coronary artery disease who received a Corus CAD (Age/Sex/Gene Expression score - ASGES) result compared to patients who did not have the test performed (matched control patients). The data collected will be from primary care practices and will also assess one to two year health outcomes (MACE, procedure complications). Furthermore, in these real world practice settings, the study will investigate the economic impact of Corus CAD (ASGES) usage at each practice using practice specific data, when available.

Eligibility

Age

21 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•For Corus CAD (Age/Sex/Gene Expression score - ASGES) arm:
•Symptoms suggestive of obstructive CAD, according to the opinion of the site clinician
•Age \>= 21 years
•Resulted Corus CAD (ASGES) test used during the evaluation and/or diagnosis of symptoms suggestive of obstructive coronary artery disease (CAD), preferably 1 year prior to data collection date.
•For Control arm:
•Symptoms suggestive of obstructive CAD, according to the opinion of the site clinician

Exclusion Criteria

•Matched to Corus CAD (ASGES) patients by sex, age +/-2.5 years, and presenting symptoms
•History of myocardial infarction (MI) or CAD prior to the index evaluation
•Presentation of high risk unstable angina for the index evaluation
•Concurrent systemic infection or inflammatory process
•Concurrent MI or acute coronary syndrome
•Known diabetes mellitus diagnosis or laboratory test results suggestive of a diagnosis of diabetes mellitus (e.g., HbA1C \>=6.5)
•Use of steroids, immunosuppressive agents, or chemotherapeutic agents, at time of chest pain presentation

Locations (9)

Internet Medical Group

Rutherford, New Jersey, United States

Triangle Primary Care

Wake Forest, North Carolina, United States

Comprehensive Physicians Associates, LLC

Youngstown, Ohio, United States

Northside Medical Center

Youngstown, Ohio, United States

J. Frank Martin, LLC

Columbia, South Carolina, United States

South Carolina Internal Medicine Associates LLC

Irmo, South Carolina, United States

Colonial Family Practice

Sumter, South Carolina, United States

Bells Medical Clinic

Bells, Texas, United States

Texas Familicare

Hurst, Texas, United States

Key Dates

Start Date

May 1, 2014

Primary Completion Date

May 1, 2015

Completion Date

June 1, 2015

Last Updated

January 31, 2019

Conditions

Coronary Artery DiseaseAngina PectorisChest PainCardiovascular DiseasesCADCVDCoronary Heart DiseaseCHD

Interventions

Corus CAD (ASGES)

DIAGNOSTIC_TEST

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

NCT05681702

Coronary Artery Disease

View study

RECRUITING

"Erectile Function After PCI in MI and Non-MI Patients"

NCT07444697

Erectile DisfunctionCoronary Artery Disease (CAD)+3 more

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 31, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making

Inclusion Criteria

Exclusion Criteria

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

"Erectile Function After PCI in MI and Non-MI Patients"

Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease

Revascularization Strategies in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) and Severe Coronary Artery Disease

Product Surveillance Registry

Essential Pro Study ( rEPIC04E-HK )